Bd, hamilton collaborate to standardize single-cell multiomics experiments using robotics

Companies to automate a critical step of high-throughput single-cell multiomics experiments franklin lakes, n.j. , jan. 23, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, announced a collaboration agreement with hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multiomics experiments.
BDX Ratings Summary
BDX Quant Ranking